These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2184514)

  • 61. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
    Sangeorzan JA; Bradley SF; He X; Zarins LT; Ridenour GL; Tiballi RN; Kauffman CA
    Am J Med; 1994 Oct; 97(4):339-46. PubMed ID: 7942935
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
    Garbino J; Lew DP; Romand JA; Hugonnet S; Auckenthaler R; Pittet D
    Intensive Care Med; 2002 Dec; 28(12):1708-17. PubMed ID: 12447512
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
    Blignaut E; Botes ME; Nieman HL
    SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Results of a double-blind study.
    Cuttner J; Troy KM; Funaro L; Brenden R; Bottone EJ
    Am J Med; 1986 Nov; 81(5):771-4. PubMed ID: 3535491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
    De Wit S; Urbain D; Rahir F; Weerts D; Clumeck N
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):503-5. PubMed ID: 1915385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.
    Revankar SG; Kirkpatrick WR; McAtee RK; Dib OP; Fothergill AW; Redding SW; Rinaldi MG; Hilsenbeck SG; Patterson TF
    Am J Med; 1998 Jul; 105(1):7-11. PubMed ID: 9688014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
    Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
    J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
    Philpott-Howard JN; Wade JJ; Mufti GJ; Brammer KW; Ehninger G
    J Antimicrob Chemother; 1993 Jun; 31(6):973-84. PubMed ID: 8360134
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.
    Parikh TB; Nanavati RN; Patankar CV; Rao S; Bisure K; Udani RH; Mehta P
    Indian Pediatr; 2007 Nov; 44(11):830-7. PubMed ID: 18057479
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Multicenter study of fluconazole in the treatment of oropharyngeal candidiasis in immunodepressed patients].
    Muñoz P; Moreno S; Garau X; López Bernaldo de Quirós JC; Berenguer J; More J; Bouza E
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):560-4. PubMed ID: 2099857
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.
    Chandrasekar PH; Gatny CM
    J Antimicrob Chemother; 1994 Feb; 33(2):309-18. PubMed ID: 8182012
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J; Esnault Y; Alemanni M
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients.
    Krcméry V; Koza I; Hornikova M; Fuchsberger P; Spanik S; Mardiak J; Sufliarsky J; Blahova M; Savko V; Migom C
    Chemotherapy; 1991; 37(5):343-5. PubMed ID: 1804594
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
    Vazquez JA; Sobel JD; Peng G; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 1999 May; 28(5):1025-31. PubMed ID: 10452629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
    Revankar SG; Dib OP; Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Redding SW; Patterson TF
    Clin Infect Dis; 1998 Apr; 26(4):960-3. PubMed ID: 9564483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
    Winston DJ; Pakrasi A; Busuttil RW
    Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.